Joel Greenblatt Gain Therapeutics, Inc. Transaction History
Gotham Asset Management, LLC
- $10.2 Billion
- Q4 2024
A detailed history of Joel Greenblatt (Gotham Asset Management, LLC) transactions in Gain Therapeutics, Inc. stock. As of the latest transaction made, Gotham Asset Management, LLC holds 158,155 shares of GANX stock, worth $300,494. This represents 0.0% of its overall portfolio holdings.
Number of Shares
158,155
Previous 334,592
52.73%
Holding current value
$300,494
Previous $595,000
45.88%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding GANX
# of Institutions
30Shares Held
2.69MCall Options Held
5.7KPut Options Held
10.6K-
David Einhorn Greenlight Capital Inc | New York, Ny588KShares$1.12 Million0.1% of portfolio
-
Dme Capital Management, LP New York, NY566KShares$1.08 Million0.06% of portfolio
-
Geode Capital Management, LLC Boston, MA267KShares$508,0990.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA177KShares$336,4420.0% of portfolio
-
Telemetry Investments, L.L.C. New York, NY123KShares$233,7000.61% of portfolio
About Gain Therapeutics, Inc.
- Ticker GANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,883,400
- Market Cap $22.6M
- Description
- Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietar...